Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

EXCEL Sub-Analysis: Angioplasty vs. Surgery in Chronic Renal Insufficiency

EXCEL patients with chronic kidney disease and left main coronary artery disease have higher rates of acute renal failure and other events compared with the general population. However, acute renal failure was less frequent with angioplasty than with surgery, while other events such as death, stroke, or infarction at 3 years were similar for both revascularization strategies and in patients with or without chronic kidney disease.

Sub análisis del EXCEL: angioplastia vs cirugía en insuficiencia renal crónicaThis study investigates the comparative effectiveness of angioplasty vs. surgery in patients with left main coronary artery disease and low or intermediate anatomical complexity according to baseline renal function values from the EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial.

 

Chronic kidney disease was defined as an estimated glomerular filtration rate <60 ml/min/1.73 m² using the CKD Epidemiology Collaboration equation. Acute renal failure or new acute flare of chronic renal failure was defined as a serum creatinine increase ≥5.0 mg/dl from baseline or a new requirement for dialysis. The primary endpoint was a classic composite of death, infarction, and stroke at 3 years.


Read also: TCT 2018 | RADIOSOUND-HTN: Testing Different Renal Ablation Techniques and Devices.


Chronic kidney disease was diagnosed in 19.3% of the global study population (361 of 1869 patients). Patients with chronic kidney disease had more events at 3 years compared with patients with regular kidney function (20.8% vs. 13.5%; hazard ratio [HR]: 1.60; 95% confidence interval [CI]: 1.22 to 2.09; p = 0.0005).

 

Acute renal failure within 30 days from the procedure obviously occurred more commonly in patients with baseline chronic disease (5.0% vs. 0.8%; p < 0.0001), and it was strongly associated with death, infarction, or stroke at 3 years (50.7% vs. 14.4%; HR: 4.59; 95% CI: 2.73 to 7.73; p < 0.0001). Acute renal failure was less common after revascularization with angioplasty compared with surgery in patients with regular renal function (0.3% vs. 1.3%) as well as in those with baseline chronic renal insufficiency (2.3% vs. 7.7%).


Read also: Renal Impairment: How Does It Affect Angioplasty and Surgery?


There were no significant differences in the primary endpoint rates after angioplasty or surgery in patients with baseline chronic kidney disease (23.4% vs. 18.1%) as well as in those with regular renal function (13.4% vs. 13.5%; p for interaction = 0.38).

 

Conclusion

Patients with chronic renal insufficiency who underwent revascularization for left main coronary artery disease in the EXCEL trial had increased rates of acute renal failure and other events. Acute renal failure was less common among patients who underwent angioplasty.

 

Original title: Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease. EXCEL Trial.

Reference: Gennaro Giustino et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...